Cargando…

The impact of type 2 diabetes and antidiabetic drugs on cancer cell growth

Despite investigations into mechanisms linking type 2 diabetes and cancer, there is a gap in knowledge about pharmacotherapy for diabetes in cancer patients. Epidemiological studies have shown that diabetic cancer patients on different antidiabetic treatments have different survival. The clinically...

Descripción completa

Detalles Bibliográficos
Autores principales:	Feng, Yin-Hsun, Velazquez-Torres, Guermarie, Gully, Christopher, Chen, Jian, Lee, Mong-Hong, Yeung, Sai-Ching Jim
Formato:	Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2011
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2930937/ https://www.ncbi.nlm.nih.gov/pubmed/20455996 http://dx.doi.org/10.1111/j.1582-4934.2010.01083.x

Ejemplares similares

Antineoplastic effects of an Aurora B kinase inhibitor in breast cancer
por: Gully, Christopher P, et al.
Publicado: (2010)

Diabetes mellitus type 2 drives metabolic reprogramming to promote pancreatic cancer growth
por: Velazquez-Torres, Guermarie, et al.
Publicado: (2020)

Nuclear export regulation of COP1 by 14-3-3σ in response to DNA damage
por: Su, Chun-Hui, et al.
Publicado: (2010)

Exenatide improves glucocorticoid-induced glucose intolerance in mice
por: Zhao, Ruiying, et al.
Publicado: (2011)

Impact of diabetes on promoting the growth of breast cancer
por: Chou, Ping‐Chieh, et al.
Publicado: (2021)

CSN6 drives carcinogenesis by positively regulating Myc stability
por: Chen, Jian, et al.
Publicado: (2014)

Cancer metabolic reprogramming: importance, main features, and potentials for precise targeted anti-cancer therapies
por: Phan, Liem Minh, et al.
Publicado: (2014)

Effects of Obesity on Transcriptomic Changes and Cancer Hallmarks in Estrogen Receptor–Positive Breast Cancer
por: Fuentes-Mattei, Enrique, et al.
Publicado: (2014)

Perspectives of Antidiabetic Drugs in Diabetes With Coronavirus Infections
por: Sun, Bao, et al.
Publicado: (2021)

Clinical Review of Antidiabetic Drugs: Implications for Type 2 Diabetes Mellitus Management
por: Chaudhury, Arun, et al.
Publicado: (2017)

Glycemic control and antidiabetic drugs in type 2 diabetes mellitus patients with renal complications
por: Huri, Hasniza Zaman, et al.
Publicado: (2015)

Noninsulin Antidiabetic Drugs for Patients with Type 2 Diabetes Mellitus: Are We Respecting Their Contraindications?
por: Ruiz-Tamayo, Irene, et al.
Publicado: (2016)

Gut Microbiota and Antidiabetic Drugs: Perspectives of Personalized Treatment in Type 2 Diabetes Mellitus
por: Liu, Wenhui, et al.
Publicado: (2022)

Optimizing weight control in diabetes: antidiabetic drug selection
por: Kalra, S, et al.
Publicado: (2010)

Pathways Targeted by Antidiabetes Drugs Are Enriched for Multiple Genes Associated With Type 2 Diabetes Risk
por: Segrè, Ayellet V., et al.
Publicado: (2015)

Development of Dementia in Type 2 Diabetes Patients: Mechanisms of Insulin Resistance and Antidiabetic Drug Development
por: Singh, Desh Deepak, et al.
Publicado: (2022)

Adherence to Oral Antidiabetic Drugs in Patients with Type 2 Diabetes: Systematic Review and Meta-Analysis
por: Piragine, Eugenia, et al.
Publicado: (2023)

Antidiabetic Drug Prescription Pattern in Hospitalized Older Patients with Diabetes
por: Ardoino, Ilaria, et al.
Publicado: (2023)

Glipizide, an antidiabetic drug, suppresses tumor growth and metastasis by inhibiting angiogenesis
por: Qi, Cuiling, et al.
Publicado: (2014)

Pharmacogenetics of Oral Antidiabetic Drugs
por: Becker, Matthijs L., et al.
Publicado: (2013)

Nephroprotective Properties of Antidiabetic Drugs
por: Gerdes, Christian, et al.
Publicado: (2023)

Acute Pancreatitis in Association With Type 2 Diabetes and Antidiabetic Drugs: A population-based cohort study
por: Gonzalez-Perez, Antonio, et al.
Publicado: (2010)

Hypoglycaemia and accident risk in people with type 2 diabetes mellitus treated with non-insulin antidiabetes drugs
por: Signorovitch, J E, et al.
Publicado: (2013)

Association between glycemic control and antidiabetic drugs in type 2 diabetes mellitus patients with cardiovascular complications
por: Huri, Hasniza Zaman, et al.
Publicado: (2015)

Comparative Efficacy of Novel Antidiabetic Drugs on Albuminuria Outcomes in Type 2 Diabetes: A Systematic Review
por: Liu, Geng, et al.
Publicado: (2023)

A variant of PSMD6 is associated with the therapeutic efficacy of oral antidiabetic drugs in Chinese type 2 diabetes patients
por: Chen, Miao, et al.
Publicado: (2015)

Evaluating the antidiabetic effects of R-verapamil in type 1 and type 2 diabetes mellitus mouse models
por: Chen, Yu-Syuan, et al.
Publicado: (2021)

Cancer and diabetes: the interlinking metabolic pathways and repurposing actions of antidiabetic drugs
por: Olatunde, Ahmed, et al.
Publicado: (2021)

Beyond Blood Sugar: Investigating the Cardiovascular Effects of Antidiabetic Drugs
por: Ahmad, Binish A, et al.
Publicado: (2023)

Relationship between the efficacy of oral antidiabetic drugs and clinical features in type 2 diabetic patients (JDDM38)
por: Kanatsuka, Azuma, et al.
Publicado: (2015)

Efficacy and safety of luseogliflozin added to various oral antidiabetic drugs in Japanese patients with type 2 diabetes mellitus
por: Seino, Yutaka, et al.
Publicado: (2015)

Remission of hyperglycemia after withdrawal of oral antidiabetic drugs in Japanese patients with early‐stage type 2 diabetes
por: Hirukawa, Hidenori, et al.
Publicado: (2018)

Glycaemic impact of treatment intensification in patients with type 2 diabetes uncontrolled with oral antidiabetes drugs or basal insulin
por: Buysman, Erin K., et al.
Publicado: (2018)

Changes in prescription patterns and doses of oral antidiabetic drugs in Japanese patients with type 2 diabetes (JDDM70)
por: Shirabe, Shinichiro, et al.
Publicado: (2022)

Cost-Effectiveness of Newer Antidiabetic Drugs as Second-Line Treatment for Type 2 Diabetes: A Systematic Review
por: Zhu, Jiejin, et al.
Publicado: (2023)

Impact of Contextual-Level Social Determinants of Health on Newer Antidiabetic Drug Adoption in Patients with Type 2 Diabetes
por: Li, Yujia, et al.
Publicado: (2023)

COP1 enhances ubiquitin-mediated degradation of p27(Kip1) to promote cancer cell growth
por: Choi, Hyun Ho, et al.
Publicado: (2015)

The Current Status of New Antidiabetic Drugs
por: Pemminati, Sudhakar, et al.
Publicado: (2016)

Cardiovascular outcomes and safety with antidiabetic drugs
por: Aldossari, Khaled K.
Publicado: (2018)

Effects of antidiabetic drugs on epicardial fat
por: Xourgia, Eleni, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_t1qroj68mvp3jt8q7spco4rsto